Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Nahon

Showing results (1-10 of 205) with videos related to

Pageof 21
Sort By:
Journal of Hepatology|May 15, 2025
Establishing five-year overall survival as a new standard for trials in advanced HCCPierre Nahon
Human Genetics|February 27, 2020
Human genetics of HCV infection phenotypes in the era of direct-acting antiviralsPierre Nahon, Aurélie Cobat
Journal of Hepatology|January 8, 2019
Fa(s)t assessment of the liver graft: Is it relevant?Pierre Nahon, Olivier Soubrane
Liver International : Official Journal of the International Association for the Study of the Liver|July 16, 2024
Atezolizumab and bevacizumab with anticoagulant or antiplatelet therapy in hepatocellular carcinoma patients: Real-world data for informed clinical decision-makingFrançois Villeret, Pierre Nahon
La Revue Du Praticien|December 5, 2018
Management and surveillance of compensated cirrhosisPierre Nahon, Daniela Fanica
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 6, 2021
Repeating Ultrasound for Hepatocellular Carcinoma Detection in Case of Inadequate Liver Visualization: A Matter of ExpertisePierre Nahon, Maxime Ronot
Journal of Hepatology|May 20, 2023
Statistical perspectives on using hepatocellular carcinoma risk models to inform surveillance decisionsHamish Innes, Pierre Nahon
Journal of Hepatology|February 23, 2023
Reply to: "Genetic factors in the clinical predictive model for hepatocellular carcinoma: Evidence from genetic association analyses"Pierre Nahon, Eric Trépo
Journal of Hepatology|January 20, 2019
Hepatocellular carcinoma in the setting of alcohol-related liver diseaseNathalie Ganne-Carrié, Pierre Nahon
Journal of Hepatology|May 22, 2012
Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosisPierre Nahon, Jessica Zucman-Rossi
Pageof 21

Showing results (1-10 of 205) with videos related to

Sort By:
Pageof 21
Journal of Hepatology|May 15, 2025
Establishing five-year overall survival as a new standard for trials in advanced HCCPierre Nahon
Human Genetics|February 27, 2020
Human genetics of HCV infection phenotypes in the era of direct-acting antiviralsPierre Nahon, Aurélie Cobat
Journal of Hepatology|January 8, 2019
Fa(s)t assessment of the liver graft: Is it relevant?Pierre Nahon, Olivier Soubrane
Liver International : Official Journal of the International Association for the Study of the Liver|July 16, 2024
Atezolizumab and bevacizumab with anticoagulant or antiplatelet therapy in hepatocellular carcinoma patients: Real-world data for informed clinical decision-makingFrançois Villeret, Pierre Nahon
La Revue Du Praticien|December 5, 2018
Management and surveillance of compensated cirrhosisPierre Nahon, Daniela Fanica
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 6, 2021
Repeating Ultrasound for Hepatocellular Carcinoma Detection in Case of Inadequate Liver Visualization: A Matter of ExpertisePierre Nahon, Maxime Ronot
Journal of Hepatology|May 20, 2023
Statistical perspectives on using hepatocellular carcinoma risk models to inform surveillance decisionsHamish Innes, Pierre Nahon
Journal of Hepatology|February 23, 2023
Reply to: "Genetic factors in the clinical predictive model for hepatocellular carcinoma: Evidence from genetic association analyses"Pierre Nahon, Eric Trépo
Journal of Hepatology|January 20, 2019
Hepatocellular carcinoma in the setting of alcohol-related liver diseaseNathalie Ganne-Carrié, Pierre Nahon
Journal of Hepatology|May 22, 2012
Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosisPierre Nahon, Jessica Zucman-Rossi
Pageof 21